LB42908

Known as: LB 42908 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2012
0120012012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Farnesyltransferase inhibitors (FTIs) have mainly been used in cancer therapy. However, more recently, investigations on these… (More)
Is this relevant?
2012
2012
Metabolism of LB42908, a novel farnesyl transferase inhibitor, was investigated for preclinical development. In vitro hepatic… (More)
Is this relevant?
2006
2006
LB42708 (LB7) and LB42908 (LB9) are pyrrole-based orally active farnesyltransferase inhibitors (FTIs) that have similar… (More)
Is this relevant?
2006
2006
As farnesylation of the Ras protein by farnesyl transferase is a critical step for the Ras functional activity, the farnesyl… (More)
Is this relevant?
2005
2005
Interleukin-12 (IL-12) gene was shown to produce both IL-12 and p40 subunit. The excess production of the p40 subunit as a… (More)
Is this relevant?
2001
2001
Design, synthesis and structure-activity relationship of a class of aryl pyrroles as farnesyltransferase inhibitors are described… (More)
Is this relevant?